Ryan Maynard - 12 Nov 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Ryan Maynard
Issuer symbol
IOVA
Transactions as of
12 Nov 2024
Transactions value $
-$130,500
Form type
4
Filing time
14 Nov 2024, 17:00:09 UTC
Previous filing
13 Jun 2024
Next filing
17 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $372,500 +50,000 +667% $7.45 57,500 12 Nov 2024 Direct F1
transaction IOVA Common Stock Sale -$503,000 -50,000 -87% $10.06 7,500 12 Nov 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Stock Option (right to buy) Options Exercise $0 -50,000 -100% $0 0 12 Nov 2024 Common Stock 50,000 $7.45 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options prior to the 10-year expiration date of such options.
F2 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F3 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105.
F4 These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015.
F5 Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person.